Merck & Co., Inc. — Director's Dealing 2023

Nov 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-10-31

Reporting Person: Downing Cristal N (Chief Comm. & Public Afrs Ofcr)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-31	Restricted Stock Unit	$	A	11685	Acquired	2026-10-31	Common Stock (11685)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 10/31/2026.